Certa Dose is a headquartered innovative medical device company in Denver, Colorado. Their first product, an U.S. Food and Drug Administration-cleared syringe, is designed for the administration of epinephrine to pediatric patients. The syringe is labeled with easy-to-recognize color zones that match the industry standard Broselow® pediatric color coding system. This helps clinicians verify the correct dose during critical, time-sensitive situations. The patented syringe incorporates the right dose, concentration, and route of administration of medication dosing, along with a color-matching technology. This system is focused on saving children’s lives by curbing critical medication errors. Founded in 2013, Certa Dose operates in the Health Care sector. Their last investment was a $2.60M Debt Financing investment on 17 July 2018.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Debt Financing | $2.60M | - | 17 Jul 2018 | |
Venture Round | $5.00M | - | 04 Jan 2018 | |
Grant | Unknown | 1 | Johnson & Johnson Robotics and Digital Solutions | 12 Dec 2017 |
Seed Round | $550.00K | - | 09 Jun 2016 | |
Seed Round | $500.00K | - | 29 Dec 2014 |
No recent news or press coverage available for Certa Dose.